.jpg)
Our BiteLabs alumni are now working at:
The UK Pharma, Life Sciences & Leadership Fellowship
Structured Learning
Group / Individual Project
Career Support
Demo Day
Networking & Industry Connections
Alumni Network
Apply for the Pharma & Leadership Fellowship – Winter 2025 cohort
30th January, 2025 – 20th March, 2025
What you'll learn through the
UK Pharma & Leadership Fellowship
Gain expertise in pharma over an 8-week Fellowship combining highly engaging live virtual sessions conducted every week with industry-led projects and global networking opportunities.
Week 1: Mindset, Leadership & Emotional Intelligence (London)
This module covers leadership, emotional intelligence, and project management from a global perspective. Through global group projects, from start to finish, participants gain practical experience in managing diverse teams, applying emotional intelligence in cross-cultural leadership, and overcoming international challenges to achieve goals.
Dr Philip Cruz: Country Medical Director at Moderna (UK)
Dr Grace Hatton: Principal Clinician at Arcturis Data; RSM Digital Health Council
Week 2: Biopharma and HealthTech in Pharma
This session delves into the integration of biopharma and healthtech within the pharmaceutical industry. It explores how biotechnological advancements and digital health technologies are revolutionising drug development, patient diagnostics, and treatment monitoring. The module examines case studies of successful biopharma and healthtech collaborations, highlighting the role of data analytics, AI, and wearable technology in enhancing drug efficacy and patient care.
Charles Leong: Vice President at GHO Capital
Konrad Dobscheutz: Ex-National Director at NHS Innovation Accelerator
Week 3: Drug Discovery, Preclinical Development and Clinical Trial Design
This module explores the drug life cycle's initial stages, including Drug Discovery and Preclinical Development, and proceeds to detail Clinical Trial Design. It emphasises the journey from identifying potential therapeutic compounds to the critical planning and execution of clinical trials. This comprehensive approach underlines the significance of ethical considerations, regulatory compliance, and the integration of technology in streamlining trial processes, ensuring data integrity, and safeguarding patient safety, offering a holistic view of drug development from conception to clinical evaluation.
Dr. Romillie Cruz, MD: Head of Medical Clinical Development, Senior Medical Director at Simbec-Orion
Evelyn Kamau: General Manager, DCT Strategy and Innovation Home Trial Services at Thermo Fisher Scientific
Week 4: Drug Life Cycle (Regulatory Affairs, Drug Approval and Launch) & Mindset
This module offers an overview of pharmaceutical regulations, concentrating on drug approval processes around the globe. It details the role of regulatory affairs in drug development, including marketing authorisation submissions, agency interactions, and compliance importance throughout the drug's lifecycle. Additionally, it addresses post-approval obligations, amendments, and regulatory document management.
Dr. Farzad Heidari: Regulatory Affairs Manager at BAP Pharma
Dr. Victor Lopez: Vice President, Medical Operations & General Manager AES
Week 5: Patient Safety, Medical Affairs, and Communication
This module examines the crucial role of medical affairs in pharmaceutical companies, focusing on their involvement in scientific communication, medical education, and stakeholder engagement. It teaches how to effectively communicate complex scientific information to diverse audiences, including healthcare professionals, patients, and regulatory bodies. The module also covers strategies for building and maintaining relationships with key stakeholders.
Dr. Mayur Joshi: Director at Global Medical Affairs Consulting; ex-Global Medical Head at Novartis
Dr. Rav Seeruthun: Chief Medical Officer at Health-equity.AI; ex-VP US Medical Affairs at Genentech
Week 6: Health Economics & Market Access and Pricing
This module introduces health economics and market access, key to pharmaceutical product commercialisation. It covers health economics principles, such as cost-effectiveness, budget impact analyses, and pricing strategies, and discusses reimbursement pathways and negotiations with healthcare payers. Fellows will learn about the importance of demonstrating value to stakeholders and using health economic data in market access strategies. The module also highlights global variations in healthcare systems and market access requirements.
Stuart Carroll: Director Market Access and Policy Affairs at Moderna
Dr. Faiz Shivji: Global Commercial Strategy Director, Immuno-Oncology, Bispecifics at AstraZeneca
Week 7: Pharmaceutical Omnichannel Marketing & Sales
This module delves into marketing and selling pharmaceutical products, highlighting product positioning, brand management, and campaign development for various stakeholders. It examines digital and traditional sales strategies, ethical marketing practices, regulatory compliance, and the influence of market access on marketing strategies. Fellows will learn about pharmaceutical sales dynamics and customer relationship management's significance.
Dr. Shaneil Sonecha: Country Medical Director at CSL Vifor (UK)
Nicolas Schmitz: Senior Manager, Strategic Market Analyst at KBI BioPharma
Week 8: Pharma & Life Sciences Summit event (London)
The final week culminates with our BiteLabs: Pharma and Life Sciences Summit event, where we host the pharma and life sciences industry, topical panel discussions and an oppertunity for our fellows to present the individual and/or group projects they have been working on during their 8 weeks fellowship programme.
Our summit event is a great opportunity for our fellows to become a part of the Pharma and Life Sciences industry by networking and raising their profiles amongst the top industry leaders.
You will ralso eceive your certificates and be formally initiated into the BiteLabs Pharma & LifeSciences Alumni Community.
BiteLabs is an EduQual-approved
Training Centre
You can now obtain a Level 7 Diploma in Pharma, Life Sciences & Industry, certified through EduQual. In addition to our 8 weeks Fellowship programme, you will be given access to our extended learning platform and undergo assessments at your own pace over 2-years.
Our Advisors, Industry Leaders, Your Mentors.
Don’t just take our word for it
Upskill or get hired
The Pharmaceutical & Leadership Diploma
Accelerate your pharmaceutical career today with our 8-week study programme.
Learn anywhere.
Winter 2025 cohort begins on the 30th January, 2025.
The full package, without accreditation.
Winter 2025 cohort begins on the 30th January, 2025.
Learn anywhere.
Winter 2025 cohort begins on the 30th January, 2025.
The full package.
Winter 2025 cohort begins on the 30th January, 2025.
Do you need help with financing?
Our admissions process.
Talk to our team (optional)
Application submission
Interview
Admission outcome
Cohort on-boarding
We are Global, with a seasoning of local
to give you that perfect bite!
Frequently asked questions
.jpeg){kind=avatar}
.jpeg){kind=avatar}
.jpeg){kind=avatar}